Candida auris otomycosis in Iran and review of recent literature.
Candida auris
Iran
emerging pathogen
multidrug resistance
Journal
Mycoses
ISSN: 1439-0507
Titre abrégé: Mycoses
Pays: Germany
ID NLM: 8805008
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
19
12
2018
revised:
20
12
2018
accepted:
21
12
2018
pubmed:
27
12
2018
medline:
5
3
2019
entrez:
27
12
2018
Statut:
ppublish
Résumé
Candida auris is a multidrug-resistant yeast emerging in immunocompromised and in otherwise healthy individuals. Due to difficulties in microbiological identification of C. auris because of the lack of available laboratory technology in developing countries, the number of patients affected is most likely underestimated. We report the first case of C. auris otitis which now adds Iran as the fifth country around the Persian Gulf, in addition to Kuwait, Oman, United Arab Emirates and Saudi Arabia. Candida auris is an unknown pathogen in routine laboratories in Iran because most Candida isolates are probably misdiagnosed. Otomycosis seems to be a different clinical presentation of C. auris mainly involving isolates from the East-Asian clade. We compared the mycological and clinical details of the Iranian patient with other cases of otitis reported since the last review of C. auris otomycosis in 2017.
Banques de données
GENBANK
['MK123931', 'EU884189']
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-105Subventions
Organisme : Mazandaran University of Medical Sciences
ID : 3085
Organisme : Mazandaran University of Medical Sciences
ID : 1262
Organisme : Mazandaran University of Medical Sciences
ID : 1222
Informations de copyright
© 2018 Blackwell Verlag GmbH.